KRAS G12D-IN-37
KRAS G12D-IN-37 is a KRASG12D inhibitor. KRAS G12D-IN-37 shows antiproliferative activity against KRASG12D mutant tumor cells and minimal cytotoxicity toward normal cells. KRAS G12D-IN-37 binds stably to KRASG12D via hydrogen bond interactions with residues His 95, Arg 68, and Asp 12, and inhibits downstream ERK/AKT signaling pathways. KRAS G12D-IN-37 elevates ROS levels, induces apoptosis, disrupts mitochondrial membrane potential. KRAS G12D-IN-37 downregulates the level of anti-apoptotic protein Bcl-2, and upregulates the levels of pro-apoptotic proteins Bax and caspase 3. KRAS G12D-IN-37 can be used for the research of cancer, such as gastric adenocarcinoma and colorectal cancer.
For research use only. We do not sell to patients.
- Formula: C29H34F3N5O3
- Molecular Weight:557.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
KRas G12D |
Bcl-2 |
Bax |
Caspase 3 |
In Vitro
KRAS G12D-IN-37 (Compound 16k) (72 h) potently inhibits the proliferation of KRASG12D-mutant AGS and GP2D cells with IC50 values of 0.18 μM and 0.21 μM, respectively, while showing lower activity against other KRAS mutant cells, KRAS wild-type cells, and normal HIEC cells[1].
KRAS G12D-IN-37 (0.31-2.5 μM; 24-72 h) exhibits time-dependent cytotoxicity against KRASG12D-mutant AGS and GP2D cells[1].
KRAS G12D-IN-37 (0.0625-0.5 μM; 14 days) potently inhibits the colony formation of KRASG12D-mutant AGS and GP2D cells in a dose-dependent manner[1].
KRAS G12D-IN-37 (0.625-2.5 μM; 6 h) inhibits the downstream ERK/AKT signaling pathways of KRAS in KRASG12D-mutant AGS and GP2D cells, reducing p-ERK and p-AKT levels in a dose-dependent manner[1].
KRAS G12D-IN-37 (0.625-2.5 μM; 24 h) dose-dependently enhances intracellular ROS accumulation and disrupts mitochondrial membrane potential in KRASG12D-mutant AGS and GP2D cells[1].
KRAS G12D-IN-37 (0.625-5 μM; 24 h) dose-dependently induces apoptosis in KRASG12D-mutant AGS and GP2D cells, dose-dependently altering the balance of pro- and anti-apoptotic proteins and increasing Caspase 3 activity[1].
KRAS G12D-IN-37 (1 μM) demonstrates favorable metabolic stability in rat liver microsomes, with a half-life of 289 min[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:KRAS G12D-mutant AGS and GP2D cells
-
Concentration:0.0625, 0.125, 0.25, 0.5 μM
-
Incubation Time:14 days (medium changes every 72 h)
-
Result:Dose-dependently inhibited colony formation of AGS and GP2D cells.
Almost entirely suppressed AGS cell colony formation at 0.25 μM; almost entirely suppressed GP2D cell colony formation at 0.5 μM.
Showed superior colony formation inhibition efficacy compared to MRTX 1133 (HY-134813).
-
Cell Line:KRAS G12D-mutant AGS and GP2D cells
-
Concentration:0.625, 1.25, 2.5 μM
-
Incubation Time:6 h
-
Result:Decreased the phosphorylation of ERK and AKT in AGS and GP2D cells.
Reduced p-AKT levels by 90% and p-ERK levels by 70% in GP2D cells at 2.5 μM; the effect on p-AKT/AKT was comparable to that of MRTX 1133.
Caused p-ERK levels to rebound at 1.25 μM in GP2D cells, potentially due to negative feedback in RAS signaling.
-
Cell Line:KRAS G12D-mutant AGS and GP2D cells
-
Concentration:0.625, 1.25, 2.5 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in AGS and GP2D cells in a dose-dependent manner.
Induced apoptosis in 80% of AGS cells at 5 μM; induced apoptosis in a high proportion of GP2D cells at 2.5 μM.
Induced higher apoptosis rates than MRTX 1133, with most apoptotic events occurring in the early stage.
-
Cell Line:KRAS G12D-mutant AGS and GP2D cells
-
Concentration:0.625, 1.25, 2.5 μM
-
Incubation Time:24 h
-
Result:Dose-dependently upregulated the levels of pro-apoptotic proteins Bax and Caspase 3, and downregulated the level of anti-apoptotic protein Bcl-2 in AGS and GP2D cells.
Dose-dependently increased Caspase 3 activity in both cell lines.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Healthy Kunming mice (equally divided by sex)[1]
-
Dosage:1500 mg/kg; 1200 mg/kg; 1000 mg/kg; 500 mg/kg
-
Administration:p.o.; single dose
-
Result:Caused death of all mice at 1500 mg/kg.
Led to death of 2 of 6 mice at 1200 mg/kg, with a calculated median lethal dose (LD50) of approximately 1270 mg/kg.
Showed no notable weight loss or physical abnormalities in mice treated with 500 mg/kg or 1000 mg/kg over 14 days.
Revealed no significant morphological changes or cellular abnormalities in heart, liver, spleen, lungs, and kidneys of mice treated with 1000 mg/kg.
Chemical Information
-
Molecular Weight 557.61
-
Formula C29H34F3N5O3
-
SMILES
FC(C1=CC=C(OC)C(C2=CC3=NC(OC[C@H]4CCCN4C)=NC(N5C[C@H](N6)CC[C@H]6C5)=C3C=C2OC)=C1)(F)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Mitochondrial membrane-potential fluorescent assay
Mitochondrial membrane potential fluorescent assays estimate ΔΨm in living cells using lipophilic cationic dyes such as TMRM, TMRE, rhodamine 123, and JC-1, which accumulate in mitochondria according to membrane polarization; loss of signal after FCCP or CCCP treatment is interpreted as mitochondrial depolarization. TMRM/TMRE and rhodamine 123 are commonly used for semi-quantitative live-cell microscopy or flow cytometry, while JC-1 can report a shift from red aggregate fluorescence to green monomer fluorescence during depolarization; interpretation requires controls because dye concentration, quenching mode, cell type, dye efflux, and mitochondrial mass can affect fluorescence independently of ΔΨm.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Fluorescent plasma-membrane potential dye assay
Fluorescent plasma-membrane potential dye assays measure changes in cell membrane potential using voltage-sensitive dyes whose fluorescence changes when cells depolarize or hyperpolarize. Anionic bis-oxonol dyes such as DiBAC4(3) enter depolarized cells more readily and show increased fluorescence after intracellular binding, while hyperpolarization reduces dye accumulation and fluorescence. FMP/FLIPR membrane-potential dyes are used for faster, homogeneous microplate assays of ion-channel or receptor-mediated membrane-potential changes.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)